Purity:SDS-PAGE

Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (avelumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (avelumab) is 98.22%, determined by SEC-HPLC.

Bioactivity:ELISA

Immobilized human PD-L1 FC at 2 ug/mL can bind Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (avelumab), EC50=0.03725 ug/mL.

Research in vivo

Avelumab inhibited the tumor growth of MC38 on hLAG3 mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 32.6% at 1 mpk at D28.

-25~-15℃保存，有效期1年。